The largest database of trusted experimental protocols

32 protocols using cd19 apc cy7

1

Splenic Immune Cell Phenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spleens were prepared and stained as described [21] (link) using the following surface antibodies for cell enumeration: biotinylated Siglec H (Hycult Biotech) and streptavidin-APC (BD Biosciences), CD11c PE-Cy7 (BD Biosciences), CD11b PerCP-Cy5.5 (Biolegend), CD19 APC-Cy7 (BD Biosciences), CD3e Pacific Blue (Biolegend), Ter-119 FITC (Biolegend). For intracellular cytokine staining the following antibodies were used: biotinylated Siglec H (streptavidin-APC), CD11c PE-Cy7, CD11b PerCP-Cy5.5, CD19 APC-Cy7, TNF Alexa 700 (BD Biosciences), IL-12p40 PE (BD Biosciences), IFNalpha FITC (Antigenix).
+ Open protocol
+ Expand
2

Antigen-specific B Cell Sorting

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cryopreserved 107 PBMC were thawed into 1 ml preheated RPMI1640, centrifuged at 300 × g for 5 min, resuspended in 500 μl FACS buffer (PBS + 2% FBS), and incubated with 200 nM his-tagged antigen (gH/gL) for 45 min at 4 °C. The PBMC were then washed two times with 1 ml FACS buffer and resuspended in 100 μl FACS buffer. The PBMC were stained with the following antibodies: CD3-PE-Cy5 (BD Biosciences Cat#555341) at a 1:25 dilution, CD14-PE-Cy5 (eBioscience Cat#15-0149-42) at a 1:50 dilution, CD16-PE-Cy5 (BD Biosciences Cat#555408) at a 1:25 dilution, CD235a-PE-Cy5 (BD Biosciences Cat#559944) at a 1:100 dilution, CD19-APC-Cy7 (BD Biosciences Cat#348794) at a 1:100 dilution, CD20-PE-Cy7 (BD Biosciences Cat#335793) at a 1:200 dilution, IgG-FITC (BD Biosciences Cat#555786) at a 1:25 dilution, and anti-his-PE (BioLegend Cat#362603) at a 1:20 dilution for 30 min at 4 °C. The PBMC were washed three times with 1 ml FACS buffer and resuspended in 500 μl FACS buffer, then subjected to FACS on a BD FACS Aria II (BD Biosciences).
Antigen-positive B cells (CD3-, CD14-, CD16-, CD235a-, CD19+, CD20+, IgG+, PE+) were sorted individually into 96-well PCR vital-plates containing 20 μl first strand buffer (5 μl first strand buffer, 0.5 μl of RNase inhibitor (Invitrogen Cat#10777019), 1.25 μl of 100 μM DTT, 0.06 μl of IGEPAL (Sigma Cat#I8896).
+ Open protocol
+ Expand
3

Comprehensive Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used: CD4-V500, CD11c-PE-Cy7, CD19-V450, CD19-APC-Cy7, CD69-PE-Cy7, IgM-PerCP-Cy5.5, CD45.2-V500, CD45.2-APC (BD Biosciences), IgD-PE, CD45.1-FITC, CD11b-PerCP-Cy5.5, CD21-PB, CD23-PE-Cy7, AA4.1-APC (eBiosciences), and CD86-PB, CD45.1-PB (BioLegend). Following red blood cell lysis, Fc receptor blockade, and staining, cells were processed on a BD FACSVerse or LSR II flow cytometer and analyzed using FlowJo v9.6.4 (Treestar).
+ Open protocol
+ Expand
4

Immunophenotyping of PBMCs in RRMS

Check if the same lab product or an alternative is used in the 5 most similar protocols
For cross-sectional study, fresh peripheral blood mononuclear cells (PBMCs) were surface stained with monoclonal antibodies against CD19-APC-cy7, CD27-FITC, CD24-BV421, CD38-BV510, and PD-L1(CD274)-PE-cy7 (BD Biosciences). For longitudinal study, frozen PBMCs, collected from 11 RRMS patients undergoing alemtuzumab at baseline and 6, 9, and 12 months, were surface stained with monoclonal antibodies as stated above.
+ Open protocol
+ Expand
5

Multiparameter Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells to be stained were resuspended in FACS buffer (HBSS containing 1% FCS) and incubated with the indicated antibodies for 15 minutes on ice. Cells were then washed in FACS buffer before acquisition on an LSR-II flow cytometer (BD Bioscience, Franklin Lakes, NJ) and analysis using Flowjo (Treestar). Antibodies (Biolegend, San Diego, CA unless otherwise stated) used were anti-mouse CD4 PerCP-Cy5.5, CD8 Pacific Blue/APC-cy7, PD-1 FITC, CXCR5-biotin (BD Bioscience), CD44 Pacific Blue, GL-7 FITC, FAS PE, CD138 APC, CD19 APC-cy7, CD23 PE, CD21 PerCP-Cy5.5, CD11b-biotin, CD11c Pacific Blue/APC, B220 PE, PDCA-1 Pacific Blue and streptavidin APC/FITC/PerCP. For intracellular staining of markers, an intracellular staining kit (Fix/Perm, eBioscience, San Diego CA) was used together with anti-mouse Foxp3 PE (eBioscience).
+ Open protocol
+ Expand
6

Activated Tfh Cells and Plasma Cells Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Activated Tfh cells in the spleen were labeled with FVS-440UV, CD45-BV786, CD3-FITC (Clone 145-2C11, BD), CD4-V500, CD8-BV605, and CXCR5-PE (Clone 2G8, BD) following surface antigen staining procedure. Subsequently, cell pallets were suspended in 1 ml fixation buffer (Cat. 554655, BD) for 15 min under room temperature and washed with 1 ml perm/wash buffer (Cat. 557885, BD) twice. Anti-mouse Bcl-6-Alexa Fluor 647 (Clone K112-91, BD) was added at 1 : 50 ratio and incubated in the dark for 30 min at 4°C. Cells were then washed twice and resuspended in cold PBS for flow cytometry assay. Plasma cells in peripheral blood cells (PBMCs) were labeled with FVS-440UV, CD45-BV786, CD3-FITC, B220-PE-Cy7, CD19-APC-cy7 (Clone 1D3, BD), and CD138-BV421 (Clone 281-2, BD) following the procedure described earlier.
+ Open protocol
+ Expand
7

Multiparameter Flow Cytometry Immunophenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fc-gamma receptors were blocked with a rat anti-mouse CD16/CD32 antibody (BD). Mouse-specific antibodies were the following: CD3-Brilliant violet 510, CD25-PercP Cy5.5, I-A/I-E-Brilliant violet 510, CD45R/B220-PE-Cy7, CD43-APC, CTLA-4-APC (all from BioLegend), CD4-APC-Cy7, CD69-PE, CD11c-PercP Cy5.5, CD19-APC-Cy7, CD40-FITC (all from BD Pharmingen), CD8α-PE-Cy7, FoxP3-FITC, CD86-APC, CD83-FITC, CD80-PE-Cy7, IgM-PercP-eFluor 710 (all from eBioscience).
During the experimental set-up, CD3 antibody was included in the staining panel (BV510 BioLegend clone 17A2) and used for the gating of T cells. The results obtained with gating on CD3+ CD4+ CD8- were similar to those obtained with gating on CD4+ CD8-. Due to the limitation in the maximum number of colours that can be discriminated with the FACS Canto II, CD3 staining was omitted in subsequent stainings.
Dead cells were excluded using the fixable viability dye-eFluor 450 (eBioscience), and intracellular staining was performed using the fixation/ permeabilization buffer set from eBioscience. Flow cytometry measurements were performed on a FACS Canto II instrument (BD) and the data were analyzed with FlowJo software (Tree Star).
+ Open protocol
+ Expand
8

Analysis of B-cell Subsets by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
To analyze the B-cell subsets, PBMCs were stained with fluorochrome-labelled anti-human CD10-APC, CD19-APC-Cy7, CD27-PC7, CD38-PercCP-Cy5.5, IgD-FITC, and IgM-PE (BD Biosciences, San Jose, CA, USA). Antibody-stained cells were analyzed by flow cytometry using FACSCANTOII and Diva software (BD Biosciences). The gating strategy is outlined in Fig 1A. The absolute numbers of subsets were obtained by multiplying their percentage by the total lymphocyte number.
+ Open protocol
+ Expand
9

Isolation and Characterization of ILCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
We depleted monocytes and granulocytes using the BD™ IMag Cell Separation system. Briefly, we performed positive selection of monocytes (Anti-CD11b Magnetic Particles, Clone M1/70) and granulocytes (Anti-Mouse Ly-6G and Ly-6C Particles, Clone RB6-8C5) as per manufacturer's instructions. The following mouse Abs were used to characterize ILCs CD55-PE (clone: RIKO-5), CD117-PE-Cy5 (clone: 2B8) and CD4-BV42 (clone: GK1.5), CD3-FITC (clone: 17A2) and CD19-APC-Cy7 (clone:6D5) (BD Bioscience, NJ, USA). To enumerate ILC subtypes, we applied a gating strategy based on the lack of expression of the classical lineage markers (CD19, CD3, CD4). We identified the ILC1 subtype as lineage markers negative (Lin-) and CD55 positivity (CD55+) (Figure 2D). Whereas ILC3s were gated and identified as Lin- CD4 positive events (Lin-CD117+, CD4+) (Figure 2F). All the data was acquired using BD FACS CANTO II flow cytometer.
+ Open protocol
+ Expand
10

Multimer-based peanut allergy analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells (PBMCs) were isolated by means of density gradient centrifugation (Ficoll-Paque Plus; GE Healthcare) from peripheral blood. These cells were then stained using CD3-APC (eBioscience clone OKT3), CD14-APC (eBioscience, clone 61D3), CD16-APC (eBioscience clone CB16), CD19-APC-Cy7 (BD Biosciences clone SJ25C1), CD27-PE (BD Pharmingen clone M-T271), CD38-Violet 421 (BD Biosciences clone HIT2), IgM-PE-Cy5 (BD Pharmingen clone G20-127), and AF488- Ara h 2 multimer. Normalization of AF488 was performed using Quantum Alexa Fluor 488 Molecules of Equivalent Soluble Fluorochrome (MESF) Beads (Bangs Laboratories, Inc). Flow cytometry was performed with an LSR II instrument (BD Biosciences). Data were analyzed using FlowJo 8.8.7 software (TreeStar). Experimental data was excluded from those samples which failed to meet quality control criteria; for example, samples with high background in the negative control (stained with the entire panel except for the Ara h 2 multimer) defined as >50 events per million CD19+ cells in the gate for multimer-positive cells were excluded (1.4% of 140 samples).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!